Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Sarcoma, Kaposi, HIV Infections

NCT04285996 2024-07-08

IMPACT

Phase NA Completed

19 enrolled

BreastGastrointestinalHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms

NCT01243333 2024-04-17

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

Phase NA Terminated

26 enrolled 11 charts

Tumor-Agnostic

Neoplasms

NCT00880074 2023-06-26

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Phase 1 Completed

10 enrolled

Tumor-Agnostic

Neoplasms

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Phase NA Completed

28 enrolled 17 charts

Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Phase NA Unknown

500 enrolled

Tumor-Agnostic

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Phase NA Unknown

30 enrolled

Tumor-Agnostic

Neoplasms

NCT04721756 2022-04-25

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Phase EARLY_PHASE1 Unknown

30 enrolled

Tumor-Agnostic

Neoplasms

NCT02287636 2020-02-24

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

Phase NA Completed

13 enrolled 5 charts

Tumor-Agnostic

Neoplasms

NCT02939456 2019-03-14

DIRMP

Phase NA Completed

150 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00588679 2019-03-08

Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla

Phase NA Completed

265 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT01123005 2017-11-06

Imaging and Biomarkers of Hypoxia in Solid Tumors

Phase 1 Terminated

28 enrolled

Tumor-Agnostic

Neoplasms

NCT00652769 2017-11-01

BOOST

Phase 3 Completed

168 enrolled

Carcinoma, Bronchogenic, Neoplasms

NCT01246726 2016-11-15

MOSS

Phase NA Terminated

9 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT01255007 2015-01-07

Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases

Phase NA Completed

50 enrolled

Body Weight, Neoplasm Metastasis, Neoplasms

NCT00492089 2014-05-09

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

Phase 2 Completed

11 enrolled 7 charts

CNSHead & Neck

Hemangiopericytoma, Malignant, Squamous Cell Carcinoma of Head and Neck, Astrocytoma, Brain Neoplasms, Ependymoma, Glioma, Meningioma, Neoplasms, Oligodendroglioma, Pinealoma, Radiation Injuries, Salivary Gland Neoplasms, Choroid Plexus Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00136890 2013-01-15

ELPET

Phase 3 Completed

337 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Neoplasms

NCT00147472 2012-06-22

Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)

Phase 3 Completed

400 enrolled

Head & Neck

Disease, Head and Neck Neoplasms, Neoplasms

Clinical Trials

PNOC028

Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Ultralow Dose PET Imaging of 18F-FDG Uptake

Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients

68-Ga-FAPI PET Imaging in Malignancy

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

IMPACT

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer

DIRMP

Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla

Imaging and Biomarkers of Hypoxia in Solid Tumors

BOOST

MOSS

Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

ELPET

Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)